Medical Disclaimer: This site provides informational comparisons only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before making medication decisions.
Compare BRIGATINIB (Alunbrig) and LAROTRECTINIB (VITRAKVI) — clinical data, side effects, and patient experiences.
Alunbrig · Targeted Cancer Therapy
How it works
12.1 Mechanism of Action Brigatinib is a tyrosine kinase inhibitor (TKI) with in vitro activity at clinically achievable concentrations against multiple kinases including ALK, ROS1...
Approved for
VITRAKVI · Targeted Cancer Therapy
How it works
12.1 Mechanism of Action Larotrectinib is an inhibitor of the tropomyosin receptor kinases (TRK), TRKA, TRKB, and TRKC. In a broad panel of purified enzyme assays, larotrectinib in...
Approved for
Estimated frequency (%) based on clinical trial data
Based on 11 Reddit discussions
BRIGATINIB
33%
positive
6 threads
LAROTRECTINIB
20%
positive
5 threads
% of discussions mentioning each side effect
6 Reddit threads analysed for BRIGATINIB
Overall Sentiment
Mixed
Comparison Threads
0
Avg Post Score
3 upvotes
Most discussed side effects in community
Do you or your loved one have experience with Brigatinib (Alunbrig) for the first line treatment of ALK Positive NSCLC? Help Lung Cancer Canada provide insight by contacting us to share your experience and help lung cancer patients get access to this treatment. Email us at [email protected].
hey all 💗 it’s been a minute. my 16yo is in the sweet spot: highly concerning tumors have grown, but are not affecting function as of now. we’ve made the decision to start brigatinib in june, at the end of the school year. we have avastin on the back burner, trying to start with least “disruptive
My father, male, age 65, was diagnosed with Stage IV non-small cell lung cancer this past June. He has since undergone whole brain radiation and began taking the medication alectinib as his cancer contains an ALK mutation. After a couple of months, the alectinib caused terrible abdominal pain and hi
hi all ✨ sending everyone some love. also, long story short, my 15yo son has NF2, and has a slowly growing VS in the left; ss deaf from removal of fast-growing binuclear VS on the right. recent growth has sparked discussions of how to preserve his hearing. we have discussed avastin, and are also l
Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.
5 Reddit threads analysed for LAROTRECTINIB
Overall Sentiment
Mixed
Comparison Threads
0
Avg Post Score
41 upvotes
Most discussed side effects in community
#/r/worldnews - **/u/glasier** **Manafort held secret talks with Assange in Ecuadorian embassy** [**Comments**](/r/worldnews/comments/a0vb9g/manafort_held_secret_talks_with_assange_in/) || [**Link**](https://www.theguardian.com/us-news/2018/nov/27/manafort-held-secret-talks-with-assange-in-ecuador
Hi everyone. I was the one who posted earlier this week asking about port experiences and doing chemo 5 days in a row. I met with my oncologist yesterday and literally everything has changed. They completed a gene fusion test on my tumor and I'm the first person with this type of presentation of ca
Hello everyone, I was a relatively healthy 33 year old until around 4 months ago when we received the news most people dread. I feel it’s very important to share my story as unfortunately, I help account for the very rare 1% of thyroid cancers and have had a relatively rough route to diagnosis and
Has anybody had experience with this drug? They are taking me off lenvima in favor of this as the lenvima hasn’t shrunk the tumor much and I have the mutation this targets.
Hi everyone! I just read about **Vitrakvi,** has anyone has experience with it? I've been actively looking for treatments for the daughter of a friend of my father. Each time I think about that we are the same age and she has struggled with cancer almost her entire life, I just wish I could help h
Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.
Both BRIGATINIB and LAROTRECTINIB belong to the Targeted Cancer Therapy class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients. BRIGATINIB is administered via Oral, whereas LAROTRECTINIB uses Oral or Oropharyngeal. Route of administration can affect onset of action and patient adherence.
Both medications are approved for 2.1 ). When two drugs treat the same condition, the choice between them often depends on the patient's medical history, other medications, tolerability, and prescriber preference.
BRIGATINIB carries 4 FDA warnings. LAROTRECTINIB carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..
This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.